Ra Pharmaceuticals Inc (RARX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -102,688 | -65,911 | -40,936 | -19,039 | -64,943 |
| Depreciation Amortization | 1,619 | 1,606 | 1,063 | 530 | 1,597 |
| Other Working Capital | -972 | -4,667 | -2,900 | -2,452 | 729 |
| Other Operating Activity | 14,680 | 10,222 | 6,384 | 2,939 | 7,671 |
| Operating Cash Flow | $-87,361 | $-58,750 | $-36,389 | $-18,022 | $-54,946 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -865 | -629 | -416 | -195 | -1,034 |
| Investing Cash Flow | $-865 | $-629 | $-416 | $-195 | $-1,034 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 144,519 | 143,282 | 1,755 | 769 | 195,798 |
| Other Financing Activity | -1,123 | -1,123 | -1,169 | -727 | -377 |
| Financing Cash Flow | $143,396 | $142,159 | $586 | $42 | $195,421 |
| Beginning Cash Position | 211,156 | 211,156 | 211,156 | 211,156 | 71,715 |
| End Cash Position | 266,326 | 293,936 | 174,937 | 192,981 | 211,156 |
| Net Cash Flow | $55,170 | $82,780 | $-36,219 | $-18,175 | $139,441 |
| Free Cash Flow | |||||
| Operating Cash Flow | -87,361 | -58,750 | -36,389 | -18,022 | -54,946 |
| Capital Expenditure | -865 | -629 | -416 | -195 | -1,034 |
| Free Cash Flow | -88,226 | -59,379 | -36,805 | -18,217 | -55,980 |